ESE3, as a tumour suppressor gene, binds directly to target genes to regulate epithelial cell differentiation, metastasis, stem-like features, epithelial-to-mesenchymal transition (EMT), tumourigenesis and tumour progression in pancreatic cancer and prostate cancer [18–21]. This evidence concerns the gene EHF and pancreatic neoplasm.